MSLN was detected in 77.4% (n = 31) of the PaC tissues and in 10% of the control tissues (n = 10), which corresponded to the non-tumor tissue adjacent to the pancreatic tumor. The gene discussed is MSLN; the disease is pancreatic neoplasm.